Medical Care
Osteogenesis Imperfecta Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 547008
- Pages: 70
- Figures: 140
- Views: 2
The global market for Osteogenesis Imperfecta Treatment was estimated to be worth US$ 688.1 million in 2023 and is forecast to a readjusted size of US$ 769.3 million by 2030 with a CAGR of 1.6% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Osteogenesis Imperfecta Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Osteogenesis Imperfecta Treatment by region & country, by Type, and by Application.
The Osteogenesis Imperfecta Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteogenesis Imperfecta Treatment.
Market Segmentation
By Company
Amgen Inc
Bone Therapeutics SA
Genzyme Corp
Mereo Biopharma Group Plc
Segment by Type:
KAL-436
BPS-804
ALLOB
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Osteogenesis Imperfecta Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Osteogenesis Imperfecta Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Osteogenesis Imperfecta Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Osteogenesis Imperfecta Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Osteogenesis Imperfecta Treatment by region & country, by Type, and by Application.
The Osteogenesis Imperfecta Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteogenesis Imperfecta Treatment.
Market Segmentation
By Company
Amgen Inc
Bone Therapeutics SA
Genzyme Corp
Mereo Biopharma Group Plc
Segment by Type:
KAL-436
BPS-804
ALLOB
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Osteogenesis Imperfecta Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Osteogenesis Imperfecta Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Osteogenesis Imperfecta Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Osteogenesis Imperfecta Treatment Product Introduction
1.2 Global Osteogenesis Imperfecta Treatment Market Size Forecast
1.3 Osteogenesis Imperfecta Treatment Market Trends & Drivers
1.3.1 Osteogenesis Imperfecta Treatment Industry Trends
1.3.2 Osteogenesis Imperfecta Treatment Market Drivers & Opportunity
1.3.3 Osteogenesis Imperfecta Treatment Market Challenges
1.3.4 Osteogenesis Imperfecta Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Osteogenesis Imperfecta Treatment Players Revenue Ranking (2023)
2.2 Global Osteogenesis Imperfecta Treatment Revenue by Company (2019-2024)
2.3 Key Companies Osteogenesis Imperfecta Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Osteogenesis Imperfecta Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Osteogenesis Imperfecta Treatment
2.6 Osteogenesis Imperfecta Treatment Market Competitive Analysis
2.6.1 Osteogenesis Imperfecta Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Osteogenesis Imperfecta Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteogenesis Imperfecta Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 KAL-436
3.1.2 BPS-804
3.1.3 ALLOB
3.1.4 Others
3.2 Global Osteogenesis Imperfecta Treatment Sales Value by Type
3.2.1 Global Osteogenesis Imperfecta Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Osteogenesis Imperfecta Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Osteogenesis Imperfecta Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Osteogenesis Imperfecta Treatment Sales Value by Application
4.2.1 Global Osteogenesis Imperfecta Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Osteogenesis Imperfecta Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Osteogenesis Imperfecta Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Osteogenesis Imperfecta Treatment Sales Value by Region
5.1.1 Global Osteogenesis Imperfecta Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Osteogenesis Imperfecta Treatment Sales Value by Region (2019-2024)
5.1.3 Global Osteogenesis Imperfecta Treatment Sales Value by Region (2025-2030)
5.1.4 Global Osteogenesis Imperfecta Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.2.2 North America Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.3.2 Europe Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.5.2 South America Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value
6.3 United States
6.3.1 United States Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.3.2 United States Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.4.2 Europe Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.5.2 China Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.6.2 Japan Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.7.2 South Korea Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.9.2 India Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Amgen Inc
7.1.1 Amgen Inc Profile
7.1.2 Amgen Inc Main Business
7.1.3 Amgen Inc Osteogenesis Imperfecta Treatment Products, Services and Solutions
7.1.4 Amgen Inc Osteogenesis Imperfecta Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Amgen Inc Recent Developments
7.2 Bone Therapeutics SA
7.2.1 Bone Therapeutics SA Profile
7.2.2 Bone Therapeutics SA Main Business
7.2.3 Bone Therapeutics SA Osteogenesis Imperfecta Treatment Products, Services and Solutions
7.2.4 Bone Therapeutics SA Osteogenesis Imperfecta Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Bone Therapeutics SA Recent Developments
7.3 Genzyme Corp
7.3.1 Genzyme Corp Profile
7.3.2 Genzyme Corp Main Business
7.3.3 Genzyme Corp Osteogenesis Imperfecta Treatment Products, Services and Solutions
7.3.4 Genzyme Corp Osteogenesis Imperfecta Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Mereo Biopharma Group Plc Recent Developments
7.4 Mereo Biopharma Group Plc
7.4.1 Mereo Biopharma Group Plc Profile
7.4.2 Mereo Biopharma Group Plc Main Business
7.4.3 Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Products, Services and Solutions
7.4.4 Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Mereo Biopharma Group Plc Recent Developments
8 Industry Chain Analysis
8.1 Osteogenesis Imperfecta Treatment Industrial Chain
8.2 Osteogenesis Imperfecta Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Osteogenesis Imperfecta Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Osteogenesis Imperfecta Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Osteogenesis Imperfecta Treatment Product Introduction
1.2 Global Osteogenesis Imperfecta Treatment Market Size Forecast
1.3 Osteogenesis Imperfecta Treatment Market Trends & Drivers
1.3.1 Osteogenesis Imperfecta Treatment Industry Trends
1.3.2 Osteogenesis Imperfecta Treatment Market Drivers & Opportunity
1.3.3 Osteogenesis Imperfecta Treatment Market Challenges
1.3.4 Osteogenesis Imperfecta Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Osteogenesis Imperfecta Treatment Players Revenue Ranking (2023)
2.2 Global Osteogenesis Imperfecta Treatment Revenue by Company (2019-2024)
2.3 Key Companies Osteogenesis Imperfecta Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Osteogenesis Imperfecta Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Osteogenesis Imperfecta Treatment
2.6 Osteogenesis Imperfecta Treatment Market Competitive Analysis
2.6.1 Osteogenesis Imperfecta Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Osteogenesis Imperfecta Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteogenesis Imperfecta Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 KAL-436
3.1.2 BPS-804
3.1.3 ALLOB
3.1.4 Others
3.2 Global Osteogenesis Imperfecta Treatment Sales Value by Type
3.2.1 Global Osteogenesis Imperfecta Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Osteogenesis Imperfecta Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Osteogenesis Imperfecta Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Osteogenesis Imperfecta Treatment Sales Value by Application
4.2.1 Global Osteogenesis Imperfecta Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Osteogenesis Imperfecta Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Osteogenesis Imperfecta Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Osteogenesis Imperfecta Treatment Sales Value by Region
5.1.1 Global Osteogenesis Imperfecta Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Osteogenesis Imperfecta Treatment Sales Value by Region (2019-2024)
5.1.3 Global Osteogenesis Imperfecta Treatment Sales Value by Region (2025-2030)
5.1.4 Global Osteogenesis Imperfecta Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.2.2 North America Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.3.2 Europe Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.5.2 South America Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value
6.3 United States
6.3.1 United States Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.3.2 United States Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.4.2 Europe Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.5.2 China Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.6.2 Japan Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.7.2 South Korea Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Osteogenesis Imperfecta Treatment Sales Value, 2019-2030
6.9.2 India Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Osteogenesis Imperfecta Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Amgen Inc
7.1.1 Amgen Inc Profile
7.1.2 Amgen Inc Main Business
7.1.3 Amgen Inc Osteogenesis Imperfecta Treatment Products, Services and Solutions
7.1.4 Amgen Inc Osteogenesis Imperfecta Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Amgen Inc Recent Developments
7.2 Bone Therapeutics SA
7.2.1 Bone Therapeutics SA Profile
7.2.2 Bone Therapeutics SA Main Business
7.2.3 Bone Therapeutics SA Osteogenesis Imperfecta Treatment Products, Services and Solutions
7.2.4 Bone Therapeutics SA Osteogenesis Imperfecta Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Bone Therapeutics SA Recent Developments
7.3 Genzyme Corp
7.3.1 Genzyme Corp Profile
7.3.2 Genzyme Corp Main Business
7.3.3 Genzyme Corp Osteogenesis Imperfecta Treatment Products, Services and Solutions
7.3.4 Genzyme Corp Osteogenesis Imperfecta Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Mereo Biopharma Group Plc Recent Developments
7.4 Mereo Biopharma Group Plc
7.4.1 Mereo Biopharma Group Plc Profile
7.4.2 Mereo Biopharma Group Plc Main Business
7.4.3 Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Products, Services and Solutions
7.4.4 Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Mereo Biopharma Group Plc Recent Developments
8 Industry Chain Analysis
8.1 Osteogenesis Imperfecta Treatment Industrial Chain
8.2 Osteogenesis Imperfecta Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Osteogenesis Imperfecta Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Osteogenesis Imperfecta Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Osteogenesis Imperfecta Treatment Market Trends
Table 2. Osteogenesis Imperfecta Treatment Market Drivers & Opportunity
Table 3. Osteogenesis Imperfecta Treatment Market Challenges
Table 4. Osteogenesis Imperfecta Treatment Market Restraints
Table 5. Global Osteogenesis Imperfecta Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Osteogenesis Imperfecta Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Osteogenesis Imperfecta Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Osteogenesis Imperfecta Treatment
Table 10. Global Osteogenesis Imperfecta Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteogenesis Imperfecta Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Osteogenesis Imperfecta Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Osteogenesis Imperfecta Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Osteogenesis Imperfecta Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Osteogenesis Imperfecta Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Osteogenesis Imperfecta Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Osteogenesis Imperfecta Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Osteogenesis Imperfecta Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Osteogenesis Imperfecta Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Osteogenesis Imperfecta Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Osteogenesis Imperfecta Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Osteogenesis Imperfecta Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Osteogenesis Imperfecta Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Osteogenesis Imperfecta Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Osteogenesis Imperfecta Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Osteogenesis Imperfecta Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Amgen Inc Basic Information List
Table 32. Amgen Inc Description and Business Overview
Table 33. Amgen Inc Osteogenesis Imperfecta Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Osteogenesis Imperfecta Treatment Business of Amgen Inc (2019-2024)
Table 35. Amgen Inc Recent Developments
Table 36. Bone Therapeutics SA Basic Information List
Table 37. Bone Therapeutics SA Description and Business Overview
Table 38. Bone Therapeutics SA Osteogenesis Imperfecta Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Osteogenesis Imperfecta Treatment Business of Bone Therapeutics SA (2019-2024)
Table 40. Bone Therapeutics SA Recent Developments
Table 41. Genzyme Corp Basic Information List
Table 42. Genzyme Corp Description and Business Overview
Table 43. Genzyme Corp Osteogenesis Imperfecta Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Osteogenesis Imperfecta Treatment Business of Genzyme Corp (2019-2024)
Table 45. Genzyme Corp Recent Developments
Table 46. Mereo Biopharma Group Plc Basic Information List
Table 47. Mereo Biopharma Group Plc Description and Business Overview
Table 48. Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Osteogenesis Imperfecta Treatment Business of Mereo Biopharma Group Plc (2019-2024)
Table 50. Mereo Biopharma Group Plc Recent Developments
Table 51. Key Raw Materials Lists
Table 52. Raw Materials Key Suppliers Lists
Table 53. Osteogenesis Imperfecta Treatment Downstream Customers
Table 54. Osteogenesis Imperfecta Treatment Distributors List
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
Table 58. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Osteogenesis Imperfecta Treatment Product Picture
Figure 2. Global Osteogenesis Imperfecta Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Osteogenesis Imperfecta Treatment Report Years Considered
Figure 5. Global Osteogenesis Imperfecta Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Osteogenesis Imperfecta Treatment Revenue in 2023
Figure 7. Osteogenesis Imperfecta Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. KAL-436 Picture
Figure 9. BPS-804 Picture
Figure 10. ALLOB Picture
Figure 11. Others Picture
Figure 12. Global Osteogenesis Imperfecta Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Osteogenesis Imperfecta Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital
Figure 15. Product Picture of Clinic
Figure 16. Product Picture of Others
Figure 17. Global Osteogenesis Imperfecta Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Osteogenesis Imperfecta Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value (%), (2019-2030)
Figure 30. United States Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 36. China Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 38. China Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. India Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. India Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. Osteogenesis Imperfecta Treatment Industrial Chain
Figure 52. Osteogenesis Imperfecta Treatment Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Osteogenesis Imperfecta Treatment Market Trends
Table 2. Osteogenesis Imperfecta Treatment Market Drivers & Opportunity
Table 3. Osteogenesis Imperfecta Treatment Market Challenges
Table 4. Osteogenesis Imperfecta Treatment Market Restraints
Table 5. Global Osteogenesis Imperfecta Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Osteogenesis Imperfecta Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Osteogenesis Imperfecta Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Osteogenesis Imperfecta Treatment
Table 10. Global Osteogenesis Imperfecta Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteogenesis Imperfecta Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Osteogenesis Imperfecta Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Osteogenesis Imperfecta Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Osteogenesis Imperfecta Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Osteogenesis Imperfecta Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Osteogenesis Imperfecta Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Osteogenesis Imperfecta Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Osteogenesis Imperfecta Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Osteogenesis Imperfecta Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Osteogenesis Imperfecta Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Osteogenesis Imperfecta Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Osteogenesis Imperfecta Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Osteogenesis Imperfecta Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Osteogenesis Imperfecta Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Osteogenesis Imperfecta Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Osteogenesis Imperfecta Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Amgen Inc Basic Information List
Table 32. Amgen Inc Description and Business Overview
Table 33. Amgen Inc Osteogenesis Imperfecta Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Osteogenesis Imperfecta Treatment Business of Amgen Inc (2019-2024)
Table 35. Amgen Inc Recent Developments
Table 36. Bone Therapeutics SA Basic Information List
Table 37. Bone Therapeutics SA Description and Business Overview
Table 38. Bone Therapeutics SA Osteogenesis Imperfecta Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Osteogenesis Imperfecta Treatment Business of Bone Therapeutics SA (2019-2024)
Table 40. Bone Therapeutics SA Recent Developments
Table 41. Genzyme Corp Basic Information List
Table 42. Genzyme Corp Description and Business Overview
Table 43. Genzyme Corp Osteogenesis Imperfecta Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Osteogenesis Imperfecta Treatment Business of Genzyme Corp (2019-2024)
Table 45. Genzyme Corp Recent Developments
Table 46. Mereo Biopharma Group Plc Basic Information List
Table 47. Mereo Biopharma Group Plc Description and Business Overview
Table 48. Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Osteogenesis Imperfecta Treatment Business of Mereo Biopharma Group Plc (2019-2024)
Table 50. Mereo Biopharma Group Plc Recent Developments
Table 51. Key Raw Materials Lists
Table 52. Raw Materials Key Suppliers Lists
Table 53. Osteogenesis Imperfecta Treatment Downstream Customers
Table 54. Osteogenesis Imperfecta Treatment Distributors List
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
Table 58. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Osteogenesis Imperfecta Treatment Product Picture
Figure 2. Global Osteogenesis Imperfecta Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Osteogenesis Imperfecta Treatment Report Years Considered
Figure 5. Global Osteogenesis Imperfecta Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Osteogenesis Imperfecta Treatment Revenue in 2023
Figure 7. Osteogenesis Imperfecta Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. KAL-436 Picture
Figure 9. BPS-804 Picture
Figure 10. ALLOB Picture
Figure 11. Others Picture
Figure 12. Global Osteogenesis Imperfecta Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Osteogenesis Imperfecta Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital
Figure 15. Product Picture of Clinic
Figure 16. Product Picture of Others
Figure 17. Global Osteogenesis Imperfecta Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Osteogenesis Imperfecta Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Osteogenesis Imperfecta Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Osteogenesis Imperfecta Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Osteogenesis Imperfecta Treatment Sales Value (%), (2019-2030)
Figure 30. United States Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 36. China Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 38. China Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. India Osteogenesis Imperfecta Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Osteogenesis Imperfecta Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. India Osteogenesis Imperfecta Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. Osteogenesis Imperfecta Treatment Industrial Chain
Figure 52. Osteogenesis Imperfecta Treatment Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232